Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS — Marco Rovaris (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS
Shared by
Massimo Filippi
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS
Article
2008
en
Authors
+4 more
MR
Marco Rovaris
EJ
Elda Judica
AC
Andrea Ceccarelli
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
Federica Agosta
,
Martina Absinta
,
Maria Pia Sormani
,
Angelo Ghezzi
,
Antonio Bertolotto
,
E. Montanari
,
Gıancarlo Comı
,
Massimo Filippi
Article
2001
Brain damage in primary-progressive MS assessed by diffusion tensor MRI
Marco Bozzali
,
Giuseppe Santuccio
,
Marco Rovaris
,
Mara Cercignani
,
Giacomo P. Comi
,
Massimo Filippi
,
Nagm
Article
2016
Patterns of Regional Gray Matter and White Matter Atrophy Progression Contributing to Clinical Deterioration in MS: A 5-Year Tensor-Based Morphometry Study (P4.136)
Paolo Preziosa
,
Maria A. Rocca
,
Elisabetta Pagani
,
Šarlota Mesaroš
,
Jelena Drulović
,
Massimo Filippi
Article
2006
Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI
Béatrice Benedetti
,
Paola Valsasina
,
Elda Judica
,
Vittorio Martinelli
,
Angelo Ghezzi
,
Ruggero Capra
,
Roberto Bergamaschi
,
Giancarlo Comi
,
Massimo Filippi
Article
2010
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up
Elisa Scola
,
Marco Bozzali
,
Federica Agosta
,
Giuseppe Magnani
,
M. Franceschi
,
Maria Pia Sormani
,
Mara Cercignani
,
Elisabetta Pagani
,
Monica Falautano
,
Massimo Filippi
,
Andrea Falini
Discussion(0)
No comments yet. Be the first to comment.